The significance of Toll-like receptor (TLR) 2 and 9 gene polymorphisms in psoriasis
Open Access
- 1 January 2017
- journal article
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 1 (1) , 85-86
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- PsoriasisThe Lancet, 2015
- Toll-Like Receptor Pathways in Autoimmune DiseasesClinical Reviews in Allergy & Immunology, 2015
- Toll‐like receptor 9 promoter polymorphism as a predictive factor of narrow‐band UVB phototherapy response in patients with psoriasisPhotodermatology, Photoimmunology & Photomedicine, 2015
- Suppression of Molecular Inflammatory Pathways by Toll-Like Receptor 7, 8, and 9 Antagonists in a Model of IL-23-Induced Skin InflammationPLOS ONE, 2013
- Toll-Like Receptors: Role in Dermatological DiseaseMediators of Inflammation, 2010
- Comparison of expression of heat‐shock protein 60, Toll‐like receptors 2 and 4, and T‐cell receptor γδ in plaque and guttate psoriasisJournal of Cutaneous Pathology, 2007
- Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin.2007
- TGF-α Regulates TLR Expression and Function on Epidermal KeratinocytesThe Journal of Immunology, 2005
- Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasisBritish Journal of Dermatology, 2003